Product News: 02 2014

This month's featured products include the cross-linking polymer film technology Strateris, which will be featured at the 72nd Annual Meeting of the American Academy of Dermatology. GlaxoSmithKline obtains US Food and Drug Administration approval of Mekinist (trametinib) tablets for use in combination with Tafinlar (dabrafenib) capsules for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations. Niadyne, Inc, launches the Priority Club to reward physicians for using its products. Promius Pharma, LLC partners with AmeriCares to launch the Promius Promise Patient Assistance Program to help patients, who are prescribed Zenatane (isotretinoin) for severe recalcitrant nodular acne, and providers meet acne treatment requirements for isotretinoin therapy.